Institutional Biosafety Committee (IBC)
California Pacific Medical Center Research Institute’s Institutional Biosafety Committee (IBC). The National Institutes of Health considers IBCs to be "the cornerstone of institutional oversight of recombinant DNA research". Committee members review any recombinant DNA studies to be carried out here and ensure they are conducted according to the NIH Guidelines.
- Institutional Biosafety Committee Standard Operating Procedures
- IBC Submission Requirements Checklist Gene Transfer Study
- CPMC Research Institute Registration Form For Recombinant DNA Experiments
- Policy on Research Involving Recombinant DNA and Hazardous Biological Materials
- IBC Summary NIH Guidelines for Research Involving Recombinant DNA Molecules
Back to top